Mandate

Vinge has advised Bona in connection with the acquisition of Ezi Floor Products

March 08, 2024

Vinge has advised Bona AB in connection with the acquisition of its distributor Ezi Floor Products (VIC) Pty Ltd in Australia.

Bona is a family-owned company which has been delivering products and systems in order to install, renovate and maintain floors since 1919. Bona has more than 600 employees and five factory sites around the world. Bona is represented in more than 90 countries through 17 subsidiaries and distributors. Bona’s head office is situated in Malmö and its turnover in 2022 amounted to SEK 3.6 billion.

Vinge, through Kristian Ford, advised Bona.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB.

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB. The final purchase price will be based on the outstanding loan volume in the portfolio as of closing date. As of March 2024, the outstanding loan volume in the portfolio amounted to approximately SEK 3.8 billion. The acquisition is subject to customary regulatory approvals.
April 22, 2024